The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Twist Bioscience's share price is $44.94.
Twist Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $5.65. Hence, Twist Bioscience's PS Ratio for today is 7.96.
The historical rank and industry rank for Twist Bioscience's PS Ratio or its related term are showing as below:
TWST'
s PS Ratio Range Over the Past 10 Years
Min: 2.96 Med: 12.55 Max: 80.47
Current: 8
During the past 9 years, Twist Bioscience's highest PS Ratio was 80.47. The lowest was 2.96. And the median was 12.55.
TWST's PS Ratio is ranked worse than 79.72% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.805
vs TWST: 8.00
During the past 12 months, the average Revenue per Share Growth Rate of Twist Bioscience was 23.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 25.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 22.90% per year.
During the past 9 years, Twist Bioscience's highest 3-Year average Revenue per Share Growth Rate was 153.90% per year. The lowest was 23.30% per year. And the median was 33.70% per year.
Back to Basics: PS Ratio
Twist Bioscience PS Ratio Historical Data
The historical data trend for Twist Bioscience's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Twist Bioscience's PS Ratio
For the Diagnostics & Research subindustry, Twist Bioscience's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Twist Bioscience's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's PS Ratio distribution charts can be found below:
* The bar in red indicates where Twist Bioscience's PS Ratio falls into.
Twist Bioscience PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Twist Bioscience's Share Price of today is $44.94. Twist Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.65.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Twist Bioscience PS Ratio Related Terms
Thank you for viewing the detailed overview of Twist Bioscience's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TWST has been successfully added to your 